Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-08-19

Clinical Trial Update: Insulin Glargine Versus Regular Insulin Based Regimens in Glycemic Control After Acute Stroke [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing insulin glargine versus regular insulin-based regimens for glycemic control after acute stroke with hyperglycemia; current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin Glargine (insulin glargine)
  • Regular insulin (insulin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Acute Stroke, Hyperglycemia | Phase 3 | Status: UNKNOWN